Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome.
作者信息
Rabut Audrey, Jasserand Ludivine, Richard Camille, Dumas Cecile, Mestrallet Fanélie, Bourbon Estelle, Gerfaud Valentin Mathieu, Heiblig Maël, Eveillard Marion, Jamilloux Yvan, Sujobert Pierre
机构信息
Hospices Civils de Lyon, Hôpital Lyon Sud, Service d'hématologie biologique, Lyon, France.
Centre Hospitalo-Universitaire de Nantes, Service d'hématologie biologique, Nantes, France.
出版信息
Hemasphere. 2023 Jan 25;7(2):e828. doi: 10.1097/HS9.0000000000000828. eCollection 2023 Feb.
Abstract
摘要
相似文献
1
Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome.
Hemasphere. 2023 Jan 25;7(2):e828. doi: 10.1097/HS9.0000000000000828. eCollection 2023 Feb.
2
Paradigm shift in monogenic autoinflammatory diseases and systemic vasculitis: The VEXAS syndrome.
Med Clin (Barc). 2022 Nov 25;159(10):489-496. doi: 10.1016/j.medcli.2022.06.018. Epub 2022 Aug 29.
3
A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm.
Blood Adv. 2022 Jan 25;6(2):405-409. doi: 10.1182/bloodadvances.2021005243.
4
The VEXAS Syndrome: Uncontrolled Inflammation and Macrocytic Anaemia in a 77-Year-Old Male Patient.
Eur J Case Rep Intern Med. 2021 Apr 13;8(4):002484. doi: 10.12890/2021_002484. eCollection 2021.
5
Looking beyond VEXAS: Coexistence of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome.
Semin Hematol. 2021 Oct;58(4):247-253. doi: 10.1053/j.seminhematol.2021.10.003. Epub 2021 Oct 9.
6
Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
Semin Hematol. 2021 Oct;58(4):204-211. doi: 10.1053/j.seminhematol.2021.10.007. Epub 2021 Oct 22.
7
Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
Mayo Clin Proc. 2021 Oct;96(10):2653-2659. doi: 10.1016/j.mayocp.2021.06.006. Epub 2021 Sep 3.
8
Thrombotic manifestations of VEXAS syndrome.
Semin Hematol. 2021 Oct;58(4):230-238. doi: 10.1053/j.seminhematol.2021.10.006. Epub 2021 Oct 25.
9
VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.
Exp Hematol Oncol. 2021 Mar 19;10(1):23. doi: 10.1186/s40164-021-00217-2.
10
USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still's Disease in Elderly Patients.
J Clin Med. 2021 Nov 27;10(23):5586. doi: 10.3390/jcm10235586.
引用本文的文献
1
Exploring patient-reported outcomes and morbidity burden of patients with VEXAS syndrome: a scoping review.
EClinicalMedicine. 2025 Jul 12;86:103354. doi: 10.1016/j.eclinm.2025.103354. eCollection 2025 Aug.
2
Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysis.
Front Immunol. 2024 Oct 3;15:1466720. doi: 10.3389/fimmu.2024.1466720. eCollection 2024.
3
VEXAS without vacuoles: Linking genotype to phenotype.
EJHaem. 2024 Oct 5;5(5):981-986. doi: 10.1002/jha2.1016. eCollection 2024 Oct.
4
Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndrome.
Blood Adv. 2023 Oct 24;7(20):6151-6155. doi: 10.1182/bloodadvances.2023010456.
5
VEXAS syndrome: a newly discovered systemic rheumatic disorder.
Reumatologia. 2023;61(2):123-129. doi: 10.5114/reum/163090. Epub 2023 May 10.
6
Recurrent Mutations of the Active Adenylation Domain of UBA1 in Atypical Form of VEXAS Syndrome.
Hemasphere. 2023 Mar 24;7(4):e868. doi: 10.1097/HS9.0000000000000868. eCollection 2023 Apr.
本文引用的文献
1
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis.
Blood. 2022 Sep 29;140(13):1496-1506. doi: 10.1182/blood.2022016985.
2
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.
Blood. 2022 Aug 25;140(8):927-931. doi: 10.1182/blood.2022016642.
3
Behçet's disease with a somatic UBA1 variant:Expanding spectrum of autoinflammatory phenotypes of VEXAS syndrome.
Clin Immunol. 2022 May;238:108996. doi: 10.1016/j.clim.2022.108996. Epub 2022 Apr 7.
4
Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.
Br J Haematol. 2022 Feb;196(4):969-974. doi: 10.1111/bjh.17893. Epub 2021 Oct 14.
5
Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
Br J Dermatol. 2022 Mar;186(3):564-574. doi: 10.1111/bjd.20805. Epub 2021 Nov 28.
6
Atypical extensive lupus tumidus-like eruption as an early presentation of VEXAS syndrome.
Int J Dermatol. 2022 Mar;61(3):e89-e91. doi: 10.1111/ijd.15916. Epub 2021 Sep 29.
7
Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1.
Blood Adv. 2021 Aug 24;5(16):3203-3215. doi: 10.1182/bloodadvances.2021004976.
8
Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold.
Br J Haematol. 2021 Oct;195(2):286-289. doi: 10.1111/bjh.17679. Epub 2021 Aug 2.
9
Atypical splice-site mutations causing VEXAS syndrome.
Rheumatology (Oxford). 2021 Dec 1;60(12):e435-e437. doi: 10.1093/rheumatology/keab524.
10
Vacuolization of hematopoietic precursors: an enigma with multiple etiologies.
Blood. 2021 Jul 1;137(26):3685-3689. doi: 10.1182/blood.2021010811.
Zotero 插件